Rozlytrek 200 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB25FBDW6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,078
Award facts
- Contract value 100% obligated
- $13,077.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rozlytrek 200 mg capsules (90 count) under a firm fixed-price contract valued at $13,077.53. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement needs across the Defense Health System and broader government healthcare networks. The SPE2DX prime vendor contract enables the company to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, specialty treatments, and medical supplies to support military healthcare programs globally. This delivery order for Rozlytrek, a targeted cancer therapy, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for federal beneficiaries, with DLA Troop Support planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FBDW6?
SPE2DB25FBDW6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FBDW6 worth?
The government has obligated $13,078 on SPE2DB25FBDW6.
Is contract SPE2DB25FBDW6 an order under another contract?
Yes. SPE2DB25FBDW6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBDW6 competed?
The extent of competition for SPE2DB25FBDW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award